Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New deputy in town

This article was originally published in The Tan Sheet

Executive Summary

Curtis Rosebraugh, MD, took over as CDER Division of OTC Drug Products deputy director effective Jan. 27. Rosebraugh has previously worked as a medical officer in the Division of Pulmonary & Allergy Drug Products, which could affect the extent to which the OTC drug division attempts to initiate Rx-to-OTC switches of the remaining second-generation antihistamines. Rosebraugh replaces Linda Katz, MD, who left to head the Office of Cosmetics & Colors Sept. 3. Rosebraugh will report to Division of OTC Drug Products Director Charles Ganley, MD...

Related Content

ODE II director





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts